The ASX 200 closed 0.19% higher at 8,899.40 on a day that swung between gains and losses as biotech Nexsen closes 43% higher after its IPO.
Austral Gold steals the show after resuming Casposo production. Also making gains: COB, RML, EUR, and ASM.
Resolution will provide a briefing on its Horse Heaven antimony project ahead of Prime Minister Anthony Albanese’s meeting with US President Donald Trump.
Property experts warn investors against chasing Airbnb riches as state governments crack down on short-term rentals.
Strong market interest in Altech Batteries’ initiatives have crystallised in the form of a $6 million placement of shares priced at 4.5c each.
Tryptamine Therapeutics have enrolled the first patient in its world-first intravenous psilocin trial for Binge Eating Disorder.
